Baumer S.A. (BVMF:BALM3)

Market Cap	151.65M
Revenue (ttm)	194.39M
Net Income (ttm)	31.61M
Shares Out	n/a
EPS (ttm)	3.23
PE Ratio	4.80
Forward PE	n/a
Dividend	1.25 (7.67%)
Ex-Dividend Date	May 7, 2025

Volume	100
Average Volume	20
Open	16.30
Previous Close	15.96
Day's Range	16.30 - 16.30
52-Week Range	9.90 - 19.00
Beta	0.46
RSI	57.30
Earnings Date	May 14, 2025

About Baumer

Baumer S.A. engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. The company offers drugs for bone regeneration, including membrane and graft; and equipment for safe environment, disinfection, preparing and inspecting, water treatment, sterilization, transfer, storage, transport, surgical room, and cleaning. It also provides orthopedic devices, such as conventional prosthesi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1952
• Employees: 306
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BALM3

Financial Performance

In 2024, Baumer's revenue was 194.39 million, an increase of 14.38% compared to the previous year's 169.95 million. Earnings were 31.61 million, an increase of 243.92%.